Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Validation and Comparison of Subjective Assessment, the International Ovarian Tumor Analysis (IOTA) ADNEX Model, Logistic Regression Model LR2, Simple Rules and the Risk of Malignancy Index (RMI) for Discrimination Between Benign and Malignant Adnexal Masses in the Hands of Ultrasound Examiners With Different Levels of Experience

NCT02847832 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT02847832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02847832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Validation and Comparison of Subjective Assessment, the International Ovarian Tumor Analysis (IOTA) ADNEX Model, Logistic Regression Model LR2, Simple Rules and the Risk of Malignancy Index (RMI) for Discrimination Between Benign and Malignant Adnexal Masses in the Hands of Ultrasound Examiners With Different Levels of Experience
Lead sponsor
KU Leuven
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2016
Completion date
December 31, 2020
Enrollment
1,700 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with adnexal mass prior to surgery